:: Volume 19, Issue 2 (2-2017) ::
JBUMS 2017, 19(2): 65-70 Back to browse issues page
High Dose Oral Calcium Treatment in Patients with Vitamin D-dependent Rickets Type II
R Vakili, S Noroozi Asl *, M Sezavar, H Zaeri
Department of Pediatrics Endocrinology, Faculty of Medicine, Mashhad university of Medical Sciences, Mashhad, I.R.Iran , norouziasls@mums.ac.ir
Abstract:   (6025 Views)

BACKGROUND AND OBJECTIVE: Vitamin D-dependent rickets type II (VDDR2) is a rare genetic disorder caused by mutations in vitamin D receptor (VDR) and leads to resistance to biological effects of calcitriol. Based on the type of mutation, this disease is resistant to calcitriol even at high doses of calcitriol and successful treatment of these patients requires hypocalcemic modification through administration of high doses of calcium and bypassing the intestinal defect in VDR signaling. In addition to the need for frequent hospitalization and high costs, intravenous administration of calcium is associated with complications and problems such as arrhythmia and sepsis, venous catheter infection and hypercalciuria. This study aims to report the positive treatment effects of high doses of oral calcium in 4 patients with vitamin D-dependent rickets type II.

CASE REPORT: In this study, 4 patients with vitamin D-dependent rickets type II, diagnosed based on clinical and biochemical symptoms of rickets with alopecia, underwent therapy using high doses of oral calcium (300 mg/kg/day) in pediatric endocrinology and metabolism center of Imam Reza hospital. After a short period, increased growth rate in height, strength and elasticity of muscles was observed in addition to biochemical improvements without serious side effects and even one patient started walking independently within the first week of therapy for the first time. Patients were regularly followed up in terms of height and weight, growth rate and biochemical factors including calcium, phosphorus and alkaline phosphatase every 3 months for one year.

CONCLUSION: Regardless of the type of mutation in vitamin D receptor, it is suggested that a 3-6 months trial of high dose oral calcium be started in each patient with vitamin D-dependent rickets type II, particularly for patients whose disease was diagnosed at lower ages.

Keywords: Vitamin D-dependent rickets type II, High dose oral calcium, Vitamin D receptor, calcitriol
Full-Text [PDF 301 kb]   (1752 Downloads)    
Type of Study: case report | Subject: CH
Received: 2016/10/6 | Accepted: 2017/02/26 | Published: 2017/03/14

XML   Persian Abstract   Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 2 (2-2017) Back to browse issues page